SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,682,021,456 |
| Positions | 21 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| KAILERA THERAPEUTICS INC | KLRA | COMMON STOCK | $497,509,394 | 22,583,268 |
| HEARTFLOW INC | HTFL | COM | $247,868,956 | 8,448,158 |
| NEWAMSTERDAM PHARMA COMPANY | NAMS | ORDINARY SHARES | $129,004,522 | 3,806,566 |
| SAVARA INC | SVRA | COM | $108,419,826 | 17,600,621 |
| ALKERMES PLC | ALKS | SHS | $101,538,262 | 1,937,938 |
| SOLID BIOSCIENCES INC | SLDB | COM NEW | $97,990,102 | 9,808,819 |
| PHARVARIS N V | PHVS | COM | $92,519,101 | 2,675,509 |
| OLEMA PHARMACEUTICALS INC | OLMA | COM | $88,636,465 | 7,085,249 |
| HEMAB THERAPEUTICS HOLDINGS INC | COAG | COM SHS | $60,604,500 | 1,650,000 |
| CABALETTA BIO INC | CABA | COM | $53,620,894 | 17,241,445 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.